Targeted polymeric nanoparticles for cancer gene therapy
Carregando...
Citações na Scopus
38
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Autores
Citação
JOURNAL OF DRUG TARGETING, v.23, n.7-8, p.627-641, 2015
Resumo
In this article, advances in designing polymeric nanoparticles for targeted cancer gene therapy are reviewed. Characterization and evaluation of biomaterials, targeting ligands, and transcriptional elements are each discussed. Advances in biomaterials have driven improvements to nanoparticle stability and tissue targeting, conjugation of ligands to the surface of polymeric nanoparticles enable binding to specific cancer cells, and the design of transcriptional elements has enabled selective DNA expression specific to the cancer cells. Together, these features have improved the performance of polymeric nanoparticles as targeted non-viral gene delivery vectors to treat cancer. As polymeric nanoparticles can be designed to be biodegradable, non-toxic, and to have reduced immunogenicity and tumorigenicity compared to viral platforms, they have significant potential for clinical use. Results of polymeric gene therapy in clinical trials and future directions for the engineering of nanoparticle systems for targeted cancer gene therapy are also presented.
Palavras-chave
Cancer therapy, cell-specificity, gene delivery, nanoparticles, polymeric biomaterial, promoter, targeting ligands, tissue-specificity
Referências
- Alberts B., 2002, MOL BIOL CELL
- DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149
- Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136
- Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125
- Poon Z, 2011, NANO LETT, V11, P2096, DOI 10.1021/nl200636r
- Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010
- Francis SM, 2014, MOL THER, V22, P1643, DOI 10.1038/mt.2014.24
- Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
- Jeong GJ, 2007, J CONTROL RELEASE, V118, P118, DOI 10.1016/j.jconrel.2006.12.009
- Parr MJ, 1997, NAT MED, V3, P1145, DOI 10.1038/nm1097-1145
- Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
- YOKOTA J, 1988, ONCOGENE, V2, P283
- Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81
- Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019
- Barh D, 2010, CURR ONCOL, V17, P70
- KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107
- Cohen JL, 2011, BIOCONJUGATE CHEM, V22, P1056, DOI 10.1021/bc100542r
- BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7
- [Anonymous], 2000, PROG INFLAM RES
- Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637
- Minn I, 2014, ADV CANCER RES, V124, P131, DOI 10.1016/B978-0-12-411638-2.00004-5
- Xiong J, 2012, CANCER-AM CANCER SOC, V118, P536, DOI 10.1002/cncr.26289
- Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
- Fields RJ, 2012, J CONTROL RELEASE, V164, P41, DOI 10.1016/j.jconrel.2012.09.020
- Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013
- Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
- Moffatt S, 2006, GENE THER, V13, P761, DOI 10.1038/sj.gt.3302721
- Kevil C, 1995, ONCOGENE, V11, P2339
- Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096
- Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338
- Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
- VILE RG, 1993, CANCER RES, V53, P962
- Lunsford L, 2000, J DRUG TARGET, V8, P39, DOI 10.3109/10611860009009208
- Prabha S, 2004, MOL PHARMACEUT, V1, P211, DOI 10.1021/mp049970+
- Tzeng SY, 2013, J BIOMED MATER RES A, V101, P1837, DOI 10.1002/jbm.a.34616
- Patel PC, 2010, BIOCONJUGATE CHEM, V21, P2250, DOI 10.1021/bc1002423
- Tinsley-Bown AM, 2000, J CONTROL RELEASE, V66, P229, DOI 10.1016/S0168-3659(99)00275-8
- Li Q, 2014, CLIN CANCER RES, V20, P2375, DOI 10.1158/1078-0432.CCR-13-1415
- Viola JR, 2010, EXPERT OPIN DRUG DEL, V7, P721, DOI 10.1517/17425241003716810
- Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y
- WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934
- DARVEAU A, 1985, P NATL ACAD SCI USA, V82, P2315, DOI 10.1073/pnas.82.8.2315
- Anton M, 2005, CANCER GENE THER, V12, P640, DOI 10.1038/sj.cgt.7700829
- O'Keefe DS, 2000, PROSTATE, V45, P149
- DeFatta RJ, 2002, CANCER GENE THER, V9, P573, DOI 10.1038/sj.cgt.7700468
- Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250
- Meric F, 2002, MOL CANCER THER, V1, P971
- Struhl K, 1995, ANNU REV GENET, V29, P651
- Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856
- Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103
- Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488
- Zhang C, 2010, BIOMATERIALS, V31, P6075, DOI 10.1016/j.biomaterials.2010.04.042
- Hedley ML, 1998, NAT MED, V4, P365, DOI 10.1038/nm0398-365
- Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023
- Menard S, 2001, ANN ONCOL, V12, P15, DOI 10.1023/A:1011151505425
- Huang YH, 2009, CANCER RES, V69, P6184, DOI 10.1158/0008-5472.CAN-09-0061
- Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894
- Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326
- Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/nmat3187, 10.1038/NMAT3187]
- Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032
- Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v
- Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.3.CO;2-I
- Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
- Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022
- Gao P, 2008, CANCER SCI, V99, P2209, DOI 10.1111/j.1349-7006.2008.00941.x
- Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010
- Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318
- Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100
- Song J, 2004, CANCER RES, V64, P7661, DOI 10.1158/0008-5472.CAN-04-1751
- Green JJ, 2007, NANO LETT, V7, P874, DOI 10.1021/nl062395b
- Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418
- Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
- Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180
- WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
- Pan CX, 1999, MED HYPOTHESES, V53, P130, DOI 10.1054/mehy.1998.0731
- Rojanarata T, 2008, PHARM RES-DORD, V25, P2807, DOI 10.1007/s11095-008-9648-6
- Nettelbeck DM, 2000, TRENDS GENET, V16, P174, DOI 10.1016/S0168-9525(99)01950-2
- Hanna N, 2012, CANCER GENE THER, V19, P374, DOI 10.1038/cgt.2012.10
- Needham CJ, 2012, BIOMACROMOLECULES, V13, P1429, DOI 10.1021/bm300145q
- Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623
- Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
- MOCHIZUKI H, 1992, MOL CARCINOGEN, V6, P83, DOI 10.1002/mc.2940060203
- Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846
- Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k
- Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102
- Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349
- ROSS JF, 1994, CANCER, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
- Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012
- Chen J, 2009, BIOMACROMOLECULES, V10, P2921, DOI 10.1021/bm900724c
- Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6
- Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077
- Bazzoni F, 2001, CANCER RES, V61, P1050
- Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165
- Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
- Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005
- Sakae M, 2008, BIOMED PHARMACOTHER, V62, P448, DOI 10.1016/j.biopha.2007.12.009
- Hildebrandt IJ, 2003, GENE THER, V10, P758, DOI 10.1038/sj.gt.3301939
- Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
- Dutta D, 2007, TOXICOL SCI, V100, P303, DOI 10.1093/toxsci/kfm217
- Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
- Li JJ, 2013, CHEM COMMUN, V49, P6974, DOI 10.1039/c3cc43576h
- Hayes GM, 2002, CANCER GENE THER, V9, P133, DOI 10.1038/sj.cgt.7700427
- Harrington KJ, 2000, ADV DRUG DELIVER REV, V44, P167, DOI 10.1016/S0169-409X(00)00093-4
- Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001
- Crew JP, 2000, BRIT J CANCER, V82, P161
- Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77
- WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
- Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931
- Robson T, 2003, J BIOMED BIOTECHNOL, P110
- Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177
- Jones HE, 2006, ENDOCR-RELAT CANCER, V13, pS45, DOI 10.1677/erc.1.01275
- Cohen JA, 2010, ADV MATER, V22, P3593, DOI 10.1002/adma.201000307
- Bayele HK, 2005, J PHARM SCI-US, V94, P446, DOI 10.1002/jps.20230
- Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107
- Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229
- Das B, 2004, P NATL ACAD SCI USA, V101, P4839, DOI 10.1073/pnas.0401011101
- Boylan NJ, 2012, J CONTROL RELEASE, V157, P72, DOI 10.1016/j.jconrel.2011.08.031
- Studeny M, 2002, CANCER RES, V62, P3603
- Hsu YY, 1999, J DRUG TARGET, V7, P313
- Knapinska AM, 2005, CURR GENOMICS, V6, P471, DOI 10.2174/138920205774482954
- Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
- Wang R, 2009, LUNG CANCER, V66, P237, DOI 10.1016/j.lungcan.2009.02.001
- GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L
- Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y
- Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035
- Benoit MA, 2001, J DRUG TARGET, V9, P253
- Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
- Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005
- Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027
- Han SE, 2009, J DRUG TARGET, V17, P123, DOI 10.1080/10611860802472461
- Akar U, 2008, AUTOPHAGY, V4, P669
- Meyer M, 2009, MOL PHARMACEUT, V6, P752, DOI 10.1021/mp9000124
- Gu JJ, 2012, BIOMATERIALS, V33, P644, DOI 10.1016/j.biomaterials.2011.09.076
- PANG S, 1995, HUM GENE THER, V6, P1417, DOI 10.1089/hum.1995.6.11-1417
- Kurosaki T, 2009, BIOMATERIALS, V30, P2846, DOI 10.1016/j.biomaterials.2009.01.055
- Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55
- Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
- Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1
- Walczak H, 1999, NAT MED, V5, P157
- Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
- Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011
- Choi KY, 2012, BIOMATERIALS, V33, P6186, DOI 10.1016/j.biomaterials.2012.05.029
- Chiu SH, 2004, J CONTROL RELEASE, V97, P357, DOI 10.1016/j.jconrel.2004.03.019
- Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
- Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
- Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698
- Manome Y, 1998, HUM GENE THER, V9, P1409, DOI 10.1089/hum.1998.9.10-1409
- Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85
- BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
- Hu BG, 2014, EXP CELL RES, V324, P183, DOI 10.1016/j.yexcr.2014.04.005
- Jafari M, 2012, CURR MED CHEM, V19, P197
- Adryan B, 2007, FLY, V1, P142
- Sestakova B, 2006, FOLIA BIOL-PRAGUE, V52, P161
- Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
- Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
- Wang Z, 2011, PHARM RES-DORDR, V28, P2983, DOI 10.1007/s11095-011-0604-5
- Alvarez RD, 2014, GYNECOL ONCOL, V133, P433, DOI 10.1016/j.ygyno.2014.03.571
- Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com
- Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X
- Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
- Kawashita Y, 1999, HUM GENE THER, V10, P1509, DOI 10.1089/10430349950017842
- Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2
- van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
- Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636
- Bivas-Benita M, 2004, EUR J PHARM BIOPHARM, V58, P1, DOI 10.1016/j.ejpb.2004.03.008
- Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
- KOROMILAS AE, 1992, EMBO J, V11, P4153
- Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334
- Jaggar RT, 1997, HUM GENE THER, V8, P2239, DOI 10.1089/hum.1997.8.18-2239
- Labhasetwar V, 1998, J PHARM SCI, V87, P1347, DOI 10.1021/js980077+
- Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215
- HARRIS JD, 1994, GENE THER, V1, P170
- Klutz K, 2011, MOL THER, V19, P676, DOI 10.1038/mt.2010.296
- Bhatia Shilpa, 2013, Discov Med, V15, P309
- Bhatnagar A, 2014, CANCER RES, V74, P5772, DOI 10.1158/0008-5472.CAN-14-0018
- Buchholz DR, 2012, XENOPUS PROTOCOL POS, P265
- Carlberg C, 2014, TRANSCRIPTION FACTOR, P55
- Chen JQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-15
- Hyo-eun CB, 2011, NAT MED, V17, P123
- Kim J, 2014, BIOCONJUGATE CHEM, V25, P43, DOI 10.1021/bc4002322
- Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074
- SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152
- Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425
- Voellmy R, 2011, J GENET SYNDR GENE T, V2, P107
- Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293
- Yao YD, 2012, SCI TRANSL MED, V4, P130, DOI 10.1126/SCITRANSLMED.3003601
- Zarogoulidis P, 2013, J GENET SYNDR GENE T, V4, P1
- Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395